Pricing Armageddon: what should investors do faced with nuclear war?
The war in Ukraine has left investment analysts pondering how to put a price on existential risks.
Russia’s invasion of Ukraine is having a far greater impact on markets than the average geopolitical incident from recent decades. There are good reasons for that.
Markets were already unsettled by the changing macroeconomic backdrop, while sanctions on this scale have never before been deployed against a major economy and huge commodity producer like Russia. But the most worrying factor is that Russia has nuclear weapons, which raises a risk that most of us haven’t seriously considered since the fall of the Berlin Wall.
In a report issued at the start of this month, analyst Peter Berezin at BCA Research estimated that there is “an uncomfortably high 10% chance of a civilisation-ending global nuclear war over the next 12 months”. The obvious question being: what does that mean for markets?
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Buy on a spike in fear
Berezin’s report has grabbed a few headlines along the lines of “nuclear war is bullish for shares”. Clearly, this isn’t his point. A story that US trader Art Cashin tells about the 1962 Cuban missile crisis is more illustrative. Cashin wanted to sell stocks, but his mentor, an experienced old hand, told him: “Look kid, if you hear the missiles are flying, you buy [stocks]. You don’t sell them... Cause if you’re wrong, the trade will never clear. We’ll all be dead.”
In other words, invest as if nuclear war won’t happen, because if it does, you won’t care about your portfolio. This makes sense. Even if you want to plan for the scenario of a devastating but survivable nuclear exchange (perhaps you have a holiday home in New Zealand), you’re still looking at a world where physical gold is about the only asset of potential use, and we’ve always suggested that MoneyWeek readers own a bit of that, so no change there.
So what’s the opportunity? Berezin argues that a spike in Google searches for “nuclear war” plus a run on potassium iodide (an anti-radiation treatment) implies that “a freak-out moment is coming, which will present a good buying opportunity for investors”. But it’s a bit more nuanced than “buy the dip”. What’s arguably more useful about Berezin’s report are his points on what a new cold war (which unlike nuclear war, seems inevitable) means for the economy.
Higher government spending on defence and alternative energy; a faster retreat from globalisation; and maybe even a tendency for households to save less, given “the ever-present danger of war”. All of these imply both higher inflation and higher interest rates. So if markets do “freak out”, be selective about the “bargains” you buy – because all of the factors that have been scaring markets for the past six months or so are only going to get worse.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
John Stepek is a senior reporter at Bloomberg News and a former editor of MoneyWeek magazine. He graduated from Strathclyde University with a degree in psychology in 1996 and has always been fascinated by the gap between the way the market works in theory and the way it works in practice, and by how our deep-rooted instincts work against our best interests as investors.
He started out in journalism by writing articles about the specific business challenges facing family firms. In 2003, he took a job on the finance desk of Teletext, where he spent two years covering the markets and breaking financial news.
His work has been published in Families in Business, Shares magazine, Spear's Magazine, The Sunday Times, and The Spectator among others. He has also appeared as an expert commentator on BBC Radio 4's Today programme, BBC Radio Scotland, Newsnight, Daily Politics and Bloomberg. His first book, on contrarian investing, The Sceptical Investor, was released in March 2019. You can follow John on Twitter at @john_stepek.
-
Christmas at Chatsworth: review of The Cavendish Hotel at Baslow
MoneyWeek Travel Matthew Partridge gets into the festive spirit at The Cavendish Hotel at Baslow and the Christmas market at Chatsworth
By Dr Matthew Partridge Published
-
Tycoon Truong My Lan on death row over world’s biggest bank fraud
Property tycoon Truong My Lan has been found guilty of a corruption scandal that dwarfs Malaysia’s 1MDB fraud and Sam Bankman-Fried’s crypto scam
By Jane Lewis Published
-
Why undersea cables are under threat – and how to protect them
Undersea cables power the internet and are vital to modern economies. They are now vulnerable
By Simon Wilson Published
-
Should you bet on US stocks?
You don’t have to be bearish on US stocks to worry that they are now such a large share of global indices
By Cris Sholto Heaton Published
-
Warren Buffet invests in Domino’s – should you buy?
What makes Domino's a compelling investment for Warren Buffet's Berkshire Hathaway, and should you buy the UK-listed takeaway pizza chain?
By Dr Matthew Partridge Published
-
Is India still a good investment?
India's long-term story is compelling, but after a spectacular bull run, warning signs are starting to show. Is investing worth the risk?
By Cris Sholto Heaton Published
-
4Imprint makes a strong impression – should you buy?
4Imprint, a specialist in marketing promotional products, is the leader in a fragmented field
By Dr Mike Tubbs Published
-
Are vintage Ladybird books valuable?
Collectables Keep an eye out for vintage Ladybird books at the car boot sale or on online marketplaces like eBay. You could find gold dust between its hard covers
By Chris Carter Published
-
Invest in Glencore: a cheap play on global growth
Glencore looks historically cheap, yet the group’s prospects remain encouraging
By Rupert Hargreaves Published
-
Alchemy: gold for the gullible
People have fallen for alchemy for centuries, including Isaac Newton and Johannes Kepler. They should have known better
By Dominic Frisby Published